Literature DB >> 2153030

Characterization of influenza A virus activation of the human neutrophil.

K L Hartshorn1, M Collamer, M R White, J H Schwartz, A I Tauber.   

Abstract

Neutrophil dysfunction consequent to influenza A virus infection has been described in vivo and in vitro and may contribute to the serious bacterial sequelae which occur in influenza-infected hosts. On the premise that such dysfunction may represent a form of "deactivation," we sought to characterize neutrophil activation by the virus in comparison with other agonists. The virus induces a respiratory burst in which H2O2 (but not O2-) are formed. Preceding the respiratory burst, a rise in intracellular calcium (Ca2+i) is noted, but both responses are nearly independent of extracellular Ca2+, unlike those elicited by the other well-characterized Ca2+-dependent agonists, formyl-methyl-leucyl-phenylalanine (FMLP), or Concanavalin-A (Con-A). The Ca2+ increase is paralleled by IP3 generation, implying that it is the result of phospholipase C (PLC) activation. The virus also elicits neutrophil membrane depolarization, which is independently mediated from the Ca2+ increase and respiratory burst and may reflect protein kinase C (PK-C) activation. Virus-induced responses are insensitive to pertussis toxin (PT); cholera toxin does inhibit these responses but in a nonspecific manner. Thus, although influenza virus activates PLC in neutrophils, it does so in a PT-insensitive manner and does not elicit or require a discernible Ca2+ influx to generate a respiratory burst response. In aggregate, the data indicate that influenza A virus activates neutrophils in a manner distinct from that of other well-described neutrophil agonists. These results illustrate the diversity of neutrophil activation mechanisms and support the notion that further characterization of this pathway may facilitate understanding of neutrophil dysfunction induced by the virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153030

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Human mannose-binding protein functions as an opsonin for influenza A viruses.

Authors:  K L Hartshorn; K Sastry; M R White; E M Anders; M Super; R A Ezekowitz; A I Tauber
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 2.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

3.  Inhibition of MLC phosphorylation restricts replication of influenza virus--a mechanism of action for anti-influenza agents.

Authors:  Mehran Haidari; Wei Zhang; Leila Ganjehei; Muzammil Ali; Zhenping Chen
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

4.  LL-37 modulates human neutrophil responses to influenza A virus.

Authors:  Shweta Tripathi; Anamika Verma; Eun-Jeong Kim; Mitchell R White; Kevan L Hartshorn
Journal:  J Leukoc Biol       Date:  2014-07-31       Impact factor: 4.962

5.  Enhancement of antiviral activity of collectin trimers through cross-linking and mutagenesis of the carbohydrate recognition domain.

Authors:  Mitchell R White; Patrick Boland; Tesfaldet Tecle; Donald Gantz; Grith Sorenson; Ida Tornoe; Uffe Holmskov; Barbara McDonald; Erika C Crouch; Kevan L Hartshorn
Journal:  J Innate Immun       Date:  2009-12-24       Impact factor: 7.349

6.  Influenza virus inhibits amiloride-sensitive Na+ channels in respiratory epithelia.

Authors:  K Kunzelmann; A H Beesley; N J King; G Karupiah; J A Young; D I Cook
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

7.  Viral aggregating and opsonizing activity in collectin trimers.

Authors:  Kevan L Hartshorn; Mitchell R White; Tesfaldet Tecle; Grith Sorensen; Uffe Holmskov; Erika C Crouch
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-16       Impact factor: 5.464

8.  Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses.

Authors:  K L Hartshorn; E C Crouch; M R White; P Eggleton; A I Tauber; D Chang; K Sastry
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  Effect of nisoldipine on priming and activation of the human neutrophil respiratory burst.

Authors:  A B Karnad; K L Hartshorn; A I Tauber
Journal:  Agents Actions       Date:  1990-08

10.  Innate immunity to influenza virus: implications for future therapy.

Authors:  Mitchell R White; Mona Doss; Patrick Boland; Tesfaldet Tecle; Kevan L Hartshorn
Journal:  Expert Rev Clin Immunol       Date:  2008-07-01       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.